Bridgefront Capital, LLC Pfizer Inc Transaction History

Bridgefront Capital, LLC

$249 Million
Q3 2024

A detailed history of Bridgefront Capital, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Bridgefront Capital, LLC holds 36,463 shares of PFE stock, worth $909,387. This represents 0.42% of its overall portfolio holdings.

Number of Shares

36,463

Previous 74,781 51.24%

Holding current value

$909,387

Previous $2.09 Million 49.57%

% of portfolio

0.42%

Previous 0.89%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$27.7 - $31.39 $1.06 Million - $1.2 Million	-38,318 Reduced 51.24%	36,463 $1.06 Million
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $1.32 Million - $1.55 Million	52,419 Added 234.41%	74,781 $2.09 Million
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $6,394 - $7,343	-247 Reduced 1.09%	22,362 $620,000
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $150,404 - $195,358	-5,756 Reduced 20.29%	22,609 $650,000
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $663,717 - $775,819	20,683 Added 269.24%	28,365 $940,000
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $65,521 - $75,807	1,814 Added 30.91%	7,682 $281,000
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $231,140 - $300,911	5,868 New	5,868 $239,000
Q4 2021 Feb 10, 2022	SELL	$41.32 - $61.25 $378,780 - $561,478	-9,167 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $359,804 - $462,200	9,167 New	9,167 $394,000
Q1 2021 May 17, 2021	SELL	$33.49 - $37.77 $1.27 Million - $1.43 Million	-37,822 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$33.47 - $42.56 $1.27 Million - $1.61 Million	37,822 New	37,822 $1.39 Million

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $140B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgefront Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgefront Capital, LLC with notifications on news.

Account

Bridgefront Capital, LLC Pfizer Inc Transaction History